X4 Pharmaceuticals XFOR Q2 2025 earnings
Reported August 8, 2025 · Before market open
Revenue$2.0MMiss by $253.4K
EPS-$3.47Beat by $1.06
Revenue estimate$2.2M
EPS estimate-$4.53
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$2.4M
EPS estimate-$0.19
Versus estimates
Revenue
Diluted EPS
Ask the moment X4 Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did X4 Pharmaceuticals report Q2 2025 earnings?
- X4 Pharmaceuticals (XFOR) reported Q2 2025 earnings on August 8, 2025 before market open.
- What were X4 Pharmaceuticals's Q2 2025 revenue and EPS?
- X4 Pharmaceuticals reported revenue of $2.0M and eps of $-3.47 for Q2 2025.
- Did X4 Pharmaceuticals beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $2.2M by $253.4K. EPS beat the consensus estimate of $-4.53 by $1.06.
- How did X4 Pharmaceuticals's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 250.4% from $563.0K a year earlier and eps declined 4857.1% from $-0.07.
- Where can I find X4 Pharmaceuticals's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001628280-25-039327) directly on SEC EDGAR. The filing index links above go to sec.gov.